Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study

Abstract

BackgroundThe COVID-19 is a significant public health issue, and monitoring confirmed cases and deaths is an essential epidemiologic tool. We evaluated the features in Brazilian hospitalized patients due to severe acute respiratory infection (SARI) during the COVID-19 pandemic in Brazil. We grouped the patients into the following categories: Influenza virus infection (G1), other respiratory viruses' infection (G2), other known etiologic agents (G3), SARS-CoV-2 infection (patients with COVID-19, G4), and undefined etiological agent (G5).MethodsWe performed an epidemiological study using data from DataSUS (https://opendatasus.saude.gov.br/) from December 2019 to October 2021. The dataset included Brazilian hospitalized patients due to SARI. We considered the clinical evolution of the patients with SARI during the COVID-19 pandemic according to the SARI patient groups as the outcome. We performed the multivariate statistical analysis using logistic regression, and we adopted an Alpha error of 0.05.ResultsA total of 2,740,272 patients were hospitalized due to SARI in Brazil, being the São Paulo state responsible for most of the cases [802,367 (29.3%)]. Most of the patients were male (1,495,416; 54.6%), aged between 25 and 60 years (1,269,398; 46.3%), and were White (1,105,123; 49.8%). A total of 1,577,279 (68.3%) patients recovered from SARI, whereas 701,607 (30.4%) died due to SARI, and 30,551 (1.3%) did not have their deaths related to SARI. A major part of the patients was grouped in G4 (1,817,098; 66.3%) and G5 (896,207; 32.7%). The other groups account for <1% of our sample [G1: 3,474 (0.1%), G2: 16,627 (0.6%), and G3: 6,866 (0.3%)]. The deaths related to SARI were more frequent in G4 (574,887; 34.7%); however, the deaths not related to SARI were more frequent among the patients categorized into the G3 (1,339; 21.3%) and G5 (25,829; 4.1%). In the multivariate analysis, the main predictors to classify the patients in the G5 when compared with G4 or G1-G4 were female sex, younger age, Black race, low educational level, rural place of residence, and the use of antiviral to treat the clinical signs. Furthermore, several features predict the risk of death by SARI, such as older age, race (Black, Indigenous, and multiracial background), low educational level, residence in a flu outbreak region, need for intensive care unit, and need for mechanical ventilatory support.ConclusionsThe possible COVID-19 underreporting (G5) might be associated with an enhanced mortality rate, more evident in distinct social groups. In addition, the patients' features are unequal between the patients' groups and can be used to determine the risk of possible COVID-19 underreporting in our population. Patients with a higher risk of death had a different epidemiological profile when compared with patients who recovered from SARI, like older age, Black, Indigenous, and multiracial background races, low educational level, residence in a flu outbreak region, need for intensive care unit and need for mechanical ventilatory support.

Profile of coronavirus disease enlightened asthma as a protective factor against death: An epidemiology study from Brazil during the pandemic

“…As several studies and ours demonstrate, age can be considered the leading independent risk factor for mortality in COVID-19 (31,34,(44)(45)(46). The main reasons for this include immunosenescence and the ability to contribute to the cytokine storm characteristic of COVID-19 (44).…”

“…We obtained the data between 17 February 2020 and 10 October 2021. In addition, the dataset used in the present study was published and validated in other studies (18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33).…”

Perfil sociodemográfico e força muscular periférica de pacientes pós Covid-19

“…A COVID-19 tem sido relacionada a fatores sociodemográficos e clínicos quanto à morbimortalidade. Neste estudo foi identificado que adultos do sexo masculino foram os mais acometidos pela COVID-19, semelhante a outros estudos (CHEN et al, 2020;HU et al, 2020;MO et al, 2020;JUN et al, 2021;SANSONE;BOSCHIERO;MARSON, 2022).…”

Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis

“…Eventually, all the reported studies were performed before the emergence of Omicron variant of concern of SARS-CoV-2 and the high dependency of EBC-based RT-qPCR on the viral nucleic acid content in the collected fluids may represent an even greater limit when dealing with these insidious pathogens. Compared to the ancestral Wuhan strain, Omicron and its subvariants have been allegedly associated with milder clinical features, that in turn appear to be associated with a different pattern of viral invasion [ 47 , 48 , 49 ]. In fact, Omicron strains seems more efficient in replicating within the mucosa of upper airways [ 50 , 51 ]: coupled with the higher efficiency in promoting breakthrough infections, this feature explains its considerably higher transmission [ 48 , 49 , 52 , 53 ], being also linked to some different features [ 48 , 53 , 54 ].…”